It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Track changes in personal budgets to understand drivers, uncover trends, and refine spending and saving habits.
22,885 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Cardano founder Charles Hoskinson publicly rejects retirement rumors that spread across social media and even reached...
German carmakers posted steep Q2 declines in China, with losses up to 41%. The drop highlights ongoing headwinds from...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...
NVIDIA posted a record-breaking $75.25 billion in Data Center revenue for its fiscal Q1 2027, a 92% year-over-year su...
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
Oil traders are watching a rumored china’s ‘secret’ billion barrel reserve as prices hold steady amid mixed Chinese i...
U.S. XRP ETF inflows remain near zero in mid-July as institutional appetite cools and on-chain activity moderates, ke...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...
A retirement couple with a $1.4 million 401(K) saw 85% of their Social Security taxed due to long-standing income thr...
A major Vanguard growth ETF is underperforming the S&P 500 this year. Here's how concentration in mega-cap tech shape...
Coeur Mining is set to release quarterly results as its stock climbs about 203% over the last 12 months. This live co...